![SANGAMO THERAPEUTICS, INC [SGMO] posts $192.28M loss as revenue rises 0.54% to $111.30M](/_next/image?url=http%3A%2F%2F10kinfo-appdata.s3.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FSGMO.png&w=3840&q=75)
SANGAMO THERAPEUTICS, INC [SGMO] posts $192.28M loss as revenue rises 0.54% to $111.30M
By USInMinutes
Published - Mar 04, 2023, 01:54 PM ET
Last Updated - Mar 06, 2023, 12:29 PM EST
| Net Sales: | $111.30M |
SANGAMO THERAPEUTICS, INC [SGMO] posted a loss of $192.28M, marking a fall of 7.84% for this year.
Revenue rose to $111.30M this year compared to $110.70M in the previous year.
According to the latest annual report the company has filed with the SEC, current earnings were $-192.28M, down 7.84% from $-178.30M.
The company’s net sales for the period were $111.30M, up 0.54%. Net sales in the previous year were $110.70M.
